172 related articles for article (PubMed ID: 23235348)
1. Clinicopathologic correlations of liver kinase B1, E-cadherin, and N-cadherin expression in non-small cell lung cancer.
Liu S; Miao Y; Fan C; Liu Y; Yu J; Zhang Y; Dai S; Wang E
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):334-40. PubMed ID: 23235348
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
3. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
[TBL] [Abstract][Full Text] [Related]
5. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
8. Loss of FGL1 induces epithelial‑mesenchymal transition and angiogenesis in LKB1 mutant lung adenocarcinoma.
Bie F; Wang G; Qu X; Wang Y; Huang C; Wang Y; Du J
Int J Oncol; 2019 Sep; 55(3):697-707. PubMed ID: 31322182
[TBL] [Abstract][Full Text] [Related]
9. LKB1 protein expression in human breast cancer.
Fenton H; Carlile B; Montgomery EA; Carraway H; Herman J; Sahin F; Su GH; Argani P
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):146-53. PubMed ID: 16785781
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression.
Jiang W; Fan H; Qian C; Ding J; Wang Q; Pang X
BMC Cancer; 2016 Jan; 16():16. PubMed ID: 26758745
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
[TBL] [Abstract][Full Text] [Related]
12. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion.
Li J; Liu J; Li P; Mao X; Li W; Yang J; Liu P
J Exp Clin Cancer Res; 2014 Sep; 33(1):70. PubMed ID: 25178656
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
[TBL] [Abstract][Full Text] [Related]
14. LKB1 mutation in large cell carcinoma of the lung.
Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
17. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
Shimamoto T; Ohyashiki JH; Hirano T; Kato H; Ohyashiki K
Oncol Rep; 2004 Aug; 12(2):389-95. PubMed ID: 15254707
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
20. LKB1 modulates lung cancer differentiation and metastasis.
Ji H; Ramsey MR; Hayes DN; Fan C; McNamara K; Kozlowski P; Torrice C; Wu MC; Shimamura T; Perera SA; Liang MC; Cai D; Naumov GN; Bao L; Contreras CM; Li D; Chen L; Krishnamurthy J; Koivunen J; Chirieac LR; Padera RF; Bronson RT; Lindeman NI; Christiani DC; Lin X; Shapiro GI; Jänne PA; Johnson BE; Meyerson M; Kwiatkowski DJ; Castrillon DH; Bardeesy N; Sharpless NE; Wong KK
Nature; 2007 Aug; 448(7155):807-10. PubMed ID: 17676035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
